Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03122483 · ClinicalTrials.gov registry record
Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)
A clinical trial, sponsored by Beckman Coulter.
- Completed
- Registry status
- 250
- Enrollment target
NCT03122483: Completed study, sponsored by Beckman Coulter.
NCT03122483 is a clinical trial that has completed, run by Beckman Coulter. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03122483 has completed, sponsored by Beckman Coulter.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
This multicenter prospective trial will evaluate the association between obstructive sleep apnea (OSA) and blood biomarkers in a representative population of consecutively enrolled symptomatic patients with a clinical suspicion of OSA.
Primary Outcome
Identification of OSA in high-risk individuals
Interventions
- DIAGNOSTIC_TEST blood biomarker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-07-14 |
What the finished NCT03122483 record still lists
NCT03122483 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which blood biomarker is the first listed.
NCT03122483 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03122483 about?
NCT03122483 is a clinical study titled "Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)". This multicenter prospective trial will evaluate the association between obstructive sleep apnea (OSA) and blood biomarkers in a representative population of consecutively enrolled symptomatic patients with a clinical suspicion of OSA.
What is the current status of trial NCT03122483?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2016-01. Estimated completion is 2017-07-14.
What interventions are being tested in trial NCT03122483?
The interventions under investigation include: blood biomarker (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03122483?
This trial is sponsored by Beckman Coulter, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia